ECOG-ACRIN EAY131-G

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol G: Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)

(See required screening study ECOG-ACRIN EAY131)

Due to the unexpectedly low prevalence of the associated targeted aberrations in our patient population, subprotocol EAY131-G is closed to accrual, effective May 16th, 2019 at 5:00 pm ET. No further treatment assignment to this subprotocol will be generated after this date, 05/16/19.

NCT#02465060